287 related articles for article (PubMed ID: 26344956)
1. Prodigiosin and its potential applications.
Darshan N; Manonmani HK
J Food Sci Technol; 2015 Sep; 52(9):5393-407. PubMed ID: 26344956
[TBL] [Abstract][Full Text] [Related]
2. The biosynthesis and regulation of bacterial prodiginines.
Williamson NR; Fineran PC; Leeper FJ; Salmond GP
Nat Rev Microbiol; 2006 Dec; 4(12):887-99. PubMed ID: 17109029
[TBL] [Abstract][Full Text] [Related]
3. Prodigiosin-like pigments.
Gerber NN
CRC Crit Rev Microbiol; 1975 May; 3(4):469-85. PubMed ID: 1095305
[TBL] [Abstract][Full Text] [Related]
4. Red bioactive pigment from Himalayan Janthinobacterium sp. ERMR3:09: optimization, characterization, and potential applications.
Mukhia S; Kumar A; Kumar R
Arch Microbiol; 2023 Dec; 206(1):44. PubMed ID: 38151568
[TBL] [Abstract][Full Text] [Related]
5. The prodigiosins: a new family of anticancer drugs.
Montaner B; Pérez-Tomás R
Curr Cancer Drug Targets; 2003 Feb; 3(1):57-65. PubMed ID: 12570661
[TBL] [Abstract][Full Text] [Related]
6. New insights on the antitumoral properties of prodiginines.
Pérez-Tomás R; Viñas M
Curr Med Chem; 2010; 17(21):2222-31. PubMed ID: 20459382
[TBL] [Abstract][Full Text] [Related]
7. Properties and applications of undecylprodigiosin and other bacterial prodigiosins.
Stankovic N; Senerovic L; Ilic-Tomic T; Vasiljevic B; Nikodinovic-Runic J
Appl Microbiol Biotechnol; 2014 May; 98(9):3841-58. PubMed ID: 24562326
[TBL] [Abstract][Full Text] [Related]
8. Recent advancements in high-level synthesis of the promising clinical drug, prodigiosin.
Yip CH; Yarkoni O; Ajioka J; Wan KL; Nathan S
Appl Microbiol Biotechnol; 2019 Feb; 103(4):1667-1680. PubMed ID: 30637495
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.
Manderville RA
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):195-218. PubMed ID: 12678767
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Anticancer Potential and Comprehensive Toxicity Studies of Novel Brominated Derivatives of Bacterial Biopigment Prodigiosin from
Lazic J; Skaro Bogojevic S; Vojnovic S; Aleksic I; Milivojevic D; Kretzschmar M; Gulder T; Petkovic M; Nikodinovic-Runic J
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744855
[TBL] [Abstract][Full Text] [Related]
11. Anticancer and immunosuppressive properties of bacterial prodiginines.
Williamson NR; Fineran PC; Gristwood T; Chawrai SR; Leeper FJ; Salmond GP
Future Microbiol; 2007 Dec; 2(6):605-18. PubMed ID: 18041902
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive profiling of quorum quenching by bacterial pigments identifies quorum sensing inhibition and antibiofilm action of prodigiosin against Acinetobacter baumannii.
Acharya K; Borborah S; Chatterjee A; Ghosh M; Bhattacharya A
Arch Microbiol; 2023 Oct; 205(12):364. PubMed ID: 37906317
[TBL] [Abstract][Full Text] [Related]
13. The prodigiosins, proapoptotic drugs with anticancer properties.
Pérez-Tomás R; Montaner B; Llagostera E; Soto-Cerrato V
Biochem Pharmacol; 2003 Oct; 66(8):1447-52. PubMed ID: 14555220
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and Bioactivity of Prodiginine Analogs in Marine Bacteria,
Sakai-Kawada FE; Ip CG; Hagiwara KA; Awaya JD
Front Microbiol; 2019; 10():1715. PubMed ID: 31396200
[TBL] [Abstract][Full Text] [Related]
15. Structures, biosynthesis, and bioactivities of prodiginine natural products.
Li P; He S; Zhang X; Gao Q; Liu Y; Liu L
Appl Microbiol Biotechnol; 2022 Dec; 106(23):7721-7735. PubMed ID: 36319792
[TBL] [Abstract][Full Text] [Related]
16. Biological Potential and Mechanism of Prodigiosin from
Li D; Liu J; Wang X; Kong D; Du W; Li H; Hse CY; Shupe T; Zhou D; Zhao K
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400387
[TBL] [Abstract][Full Text] [Related]
17. Tautomeric equilibria in phenolic A-ring derivatives of prodigiosin natural products.
La JQ; Michaelides AA; Manderville RA
J Phys Chem B; 2007 Oct; 111(40):11803-11. PubMed ID: 17867672
[TBL] [Abstract][Full Text] [Related]
18. Bacterial Pigment Prodigiosin Demonstrates a Unique Antiherpesvirus Activity That Is Mediated through Inhibition of Prosurvival Signal Transducers.
Suryawanshi RK; Koujah L; Patil CD; Ames JM; Agelidis A; Yadavalli T; Patil SV; Shukla D
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295926
[TBL] [Abstract][Full Text] [Related]
19. Development of natural anti-tumor drugs by microorganisms.
Chang CC; Chen WC; Ho TF; Wu HS; Wei YH
J Biosci Bioeng; 2011 May; 111(5):501-11. PubMed ID: 21277252
[TBL] [Abstract][Full Text] [Related]
20. The anticancer agent prodigiosin is not a multidrug resistance protein substrate.
Elahian F; Moghimi B; Dinmohammadi F; Ghamghami M; Hamidi M; Mirzaei SA
DNA Cell Biol; 2013 Mar; 32(3):90-7. PubMed ID: 23373476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
